---
schema_version: "secwatch.filing_event.v1"
accession: "0001755672-26-000002"
form_type: "8-K"
ticker: "CTVA"
cik: "0001755672"
company_name: "Corteva, Inc."
filed_at: "2026-02-03T23:59:59+00:00"
generated_at: "2026-05-16T05:21:52.751980+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Corteva FY2025 sales $17.4B (+3%), EBITDA $3.85B; guides 2026 EBITDA $4.0-4.2B; settles Bayer

## Summary
- Full-year GAAP EPS from cont ops $1.75, up 43% YoY; Operating EPS $3.34, up 30%.
- Seed net sales $9.9B (+4%), driven by price/mix +3% and volume +2%; operating EBITDA $2.64B (+19%).
- Crop Protection net sales $7.5B (+2%), volume +5% offset by price -2%; operating EBITDA $1.35B (+6%).
- Resolved all Bayer litigation; $610M cash outflow in Q1 2026; accelerates path to royalty neutrality by 2 years; expects $1B earnings upside over decade.
- Full-year 2026 guidance: Operating EBITDA $4.0-4.2B, Operating EPS $3.45-$3.70, implying ~7% growth.

## SEC filing metadata
- accession: 0001755672-26-000002
- form_type: 8-K
- ticker: CTVA
- cik: 0001755672
- company_name: Corteva, Inc.
- filed_at: 2026-02-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1755672/000175567226000002/0001755672-26-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1755672/000175567226000002/ctva-20260203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001755672-26-000002
- JSON: https://secwatch.observer/filing/0001755672-26-000002.json
- Plain text: https://secwatch.observer/filing/0001755672-26-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.